コンテンツへスキップ
Merck
  • Microglia replacement by microglia transplantation (Mr MT) in the adult mouse brain.

Microglia replacement by microglia transplantation (Mr MT) in the adult mouse brain.

STAR protocols (2021-07-27)
Zhen Xu, Bo Peng, Yanxia Rao
要旨

Mutations in microglia may cause brain disorders. Replacement of dysfunctional microglia by allogeneic wild-type microglia from bone marrow transplantation (Mr BMT) or peripheral blood can correct the gene deficiency at the brain-wide scale but cannot achieve precise replacement at specific brain regions. Here, we introduce a strategy with potential clinical relevance-microglia replacement by microglia transplantation (Mr MT), combining tamoxifen-induced ablation of Mr BMT cells and intracranial injection of microglia to mouse brain, to achieve region-sepcific microglia replacement. The original abbreviation of this microglia replacement strategy is mrMT. We hereby change the name to Mr MT. For complete details on the use and execution of this protocol, please refer to Xu et al. (2020).

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
コレステロール, Sigma Grade, ≥99%
Sigma-Aldrich
N-アセチル-L-システイン, BioReagent, suitable for cell culture
Sigma-Aldrich
L-システイン, 97%
Sigma-Aldrich
アポトランスフェリン ヒト, powder, BioReagent, suitable for cell culture, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
オレイン酸, BioReagent, suitable for cell culture
Sigma-Aldrich
キシラジン 塩酸塩, ≥99.0% (HPLC)
Sigma-Aldrich
cis-11-エイコセン酸, ≥99% (capillary GC)
Sigma-Aldrich
メロキシカム ナトリウム塩 水和物, ≥98% (HPLC)